Corporate Profile

We are a clinical stage biotechnology company developing first-in-class antibody product candidates focused on unmet medical needs in inflammation.

More
ANAB (Common Stock) $64.67 Stock is Down 2.07 (3.10%)10/20/17 4:00 p.m. ET
Stock chart for: ANAB.O.  Currently trading at $64.67 with a 52 week high of $74.00 and a 52 week low of $15.17.
Data provided by Nasdaq. Minimum 15 minutes delayed.




Upcoming Events


  |   |   |   |   |